Amneal Pharmaceuticals Inc.
Organization details
- Legal name
- Amneal Pharmaceuticals Inc.
- Former names
- Atlas Holdings, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AMRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001723128
- Wikidata ID
- Q16996714
Board of directors
-
Chintu Patel · Director · Co-CEOSince 2023
-
Chirag K. Patel · Director · President & Co-CEOSince 2023
-
Deborah M. Autor · DirectorSince 2023
-
Emily Peterson Alva · DirectorSince 2023
-
Gautam Patel · DirectorSince 2023
-
J. Kevin Buchi · DirectorSince 2023
-
Jeffrey P. George · DirectorSince 2023
-
John Kiely · DirectorSince 2023
- Since 2023
-
Shlomo Yanai · DirectorSince 2023
-
Ted C. Nark · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
87.5%
-
88.3%
-
90.9%
-
92.3%
-
92.3%
-
97.7%
-
99.5%
-
99.5%
-
99.6%
Board connections
7 of this board's directors also sit on 12 other boards. 5 are in the same sector.
- via Jeffrey P. George
-
Alkermes plc Same sectorvia Emily Peterson Alva
-
Anavex Life Sciences Corp. Same sectorvia Gautam Patel
- via Paul M. Meister
-
Benitec Biopharma Inc. Same sectorvia J. Kevin Buchi
-
Hims & Hers Health Inc. Same sectorvia Deborah M. Autor
-
LENZ Therapeutics Inc. Same sectorvia Jeffrey P. George
- via Paul M. Meister
- via Shlomo Yanai
- via Paul M. Meister
- via Gautam Patel
- via Paul M. Meister
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $9,824,848
- 7 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | J. Kevin Buchi Director | Gift | −20,445 | — | — |
| Sep 11, 2026 | J. Kevin Buchi Director | Option exercise | +20,445 | $14.45 | $295,430 |
| Sep 1, 2026 | BOYER ANDREW S Officer (Executive Vice President) | Gift | −80,000 | — | — |
| Aug 21, 2026 | BOYER ANDREW S Officer (Executive Vice President) | Gift | −152,426 | — | — |
| Aug 13, 2026 | John Kiely Director | Open-market sale | −50,000 | $17.64 | $882,000 |
| Aug 13, 2026 | John Kiely Director | Gift | −10,000 | — | — |
| Aug 12, 2026 | Shah Nikita Officer (Executive Vice President) | Open-market sale | −146,403 | $17.51 | $2,563,517 |
| Aug 12, 2026 | Daly Jason B. Officer (EVP, Chief Legal Officer) | Open-market sale | −210,000 | $17.40 | $3,654,000 |
| Aug 11, 2026 | J. Kevin Buchi Director | Option exercise | −168,573 | $17.18 | $2,896,084 |
| Aug 11, 2026 | Daly Jason B. Officer (EVP, Chief Legal Officer) | Open-market sale | −6,613 | $17.70 | $117,050 |
| Aug 10, 2026 | Patel Tushar Bhikhubhai 10% owner | Grant or award | +12,763,469 | — | — |
| Aug 10, 2026 | Chirag K. Patel Director, Officer (President & Co-CEO) | Grant or award | +6,381,734 | — | — |
| Aug 10, 2026 | Gautam Patel Director | Grant or award | +283,632 | — | — |
| Aug 10, 2026 | Chintu Patel Director, Officer (Co-CEO) | Grant or award | +6,381,734 | — | — |
| May 11, 2026 | Deborah M. Autor Director | Open-market sale | −34,819 | $12.94 | $450,558 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Amneal Pharmaceuticals Inc.
Who is the CEO of Amneal Pharmaceuticals Inc.?
Chintu Patel is Amneal Pharmaceuticals Inc.'s Co-CEO.
How many directors are on Amneal Pharmaceuticals Inc.'s board?
Amneal Pharmaceuticals Inc.'s board has 11 directors: Chintu Patel, Chirag K. Patel, Deborah M. Autor, Emily Peterson Alva, Gautam Patel, J. Kevin Buchi, Jeffrey P. George, John Kiely, Paul M. Meister, Shlomo Yanai and 1 other.
Are Amneal Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Amneal Pharmaceuticals Inc. insiders made no open-market purchases and sold $9.8 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="amneal-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.